期刊文献+

两个血浆-效应室平衡速率常数值用于靶控丙泊酚效应位浓度对血流动力学的影响 被引量:7

Effect of target-controlled effect-site concentration of propofol on hemodynamics
暂未订购
导出
摘要 目的比较听觉诱发电位指数和双频指数监测计算的血浆-效应室平衡速率常数(ke0)应用于控制效应位浓度输注系统对血流动力学的影响,以评价其临床应用的安全性。方法85例不用术前药的患者分为TP组(39例)、TE1组(23例)和TE2组(23例),TP组靶控血浆浓度,TE1组和TE2组分别应用ke0=0.62/min和1.83/min的靶控效应室浓度,记录血压、心率和患者意识消失的时间。结果TP组的意识消失的时间为75s,显著长于TE1和TE2组的40s(P值均<0.05)。3组间收缩压降低的最大幅度、达到最大降幅的时间以及心率变化的差异均无统计学意义(P值均>0.05)。结论相对于靶控血浆浓度,靶控效应室浓度缩短了达到意识消失的时间,同时不会增加血压降低的幅度。 Objective To compare the effects of target-controlled plasma concentration and effect-site concentrations (2 ke0s) of propofol on hemodynamics in Chinese patients. Methods Eighty-five patients were divided to 3 groups.. TP (TCI device controlled the plasma concentration, n = 39), TE1 and TE2 groups (TCI device controlled the effect-site concentration with the values of ke0 0.62/rain, and 1.83/min, respectively, n= 23 each). Blood pressure, heart rate and the time of loss of consciousness (LOC) were an recorded. Results The time of LOC was significantly longer in TP group (75 s) than those in the TEl and TE2 groups (40 s and 40 s, P〈 0.05). The maximum amplitude of hypotension, the time to the lowest blood pressure, and the change of heart rate were similar among 3 groups (all P〉 0.05). Conclusion Target-controlled effect-site concentration of propofol can shorten the time of unconsciousness and has no negative effect on patients hemodymamics compared with target-controlled plasma concentration of propofol.
出处 《上海医学》 CAS CSCD 北大核心 2009年第1期43-45,共3页 Shanghai Medical Journal
关键词 麻醉药 丙泊酚 药效动力学 血浆-效应室平衡速率常数 Anaesthetics Propofol Pharmacodynamic Plasma effect site equilibration rate constant
  • 相关文献

参考文献3

二级参考文献25

  • 1徐辉,张马忠,张跃.年龄对丙泊酚药效学的影响[J].医学理论与实践,2004,17(9):1026-1028. 被引量:3
  • 2王强,徐军,刘礼军,何风勇.硬膜外麻醉下靶控输注丙泊酚镇静对血液动力学的影响[J].临床麻醉学杂志,2005,21(8):514-515. 被引量:7
  • 3黄咏磊,张马忠,郭旋,王珊娟,刘万枫,杭燕南.硬膜外麻醉中不同药代学参数丙泊酚靶控输注的药效学[J].上海交通大学学报(医学版),2006,26(1):84-86. 被引量:3
  • 4Schnider TW,minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology, 1999, 90:1502-1506.
  • 5Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology, 1994, 81:820-828.
  • 6Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg,1999, 89(4 suppl): S7-S14.
  • 7Vuyk J, Mertens MJ, Olofsen E, et al. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC90 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology,1997, 81: 1549-1562.
  • 8Troy AM, Huthinson RC, Easy WR, et al. Treacheal intubating conditions using propofol and remifentanil target-controlled infusions, Anaesthesia, 2002, 57: 1204-1207.
  • 9Glass PSA, shafer SL, Reves JG. Intravenous drug delivery system. In: Miller RD, ed. Anesthesia. 5th edn. New York:Churchill Livingstone, 2001. 377-440.
  • 10Hoymork SC, Raeder J, Grimsmo B, et al. Bispectral index,predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand, 2000, 44:1138-1144.

共引文献27

同被引文献75

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部